These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2009091)
21. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Hesse LM; Venkatakrishnan K; von Moltke LL; Shader RI; Greenblatt DJ Drug Metab Dispos; 2001 Feb; 29(2):133-40. PubMed ID: 11159802 [TBL] [Abstract][Full Text] [Related]
22. Hydroxylation of the antimalarial drug 58C80 by CYP2C9 in human liver microsomes: comparison with mephenytoin and tolbutamide hydroxylations. Weaver RJ; Dickins M; Burke MD Biochem Pharmacol; 1995 Mar; 49(7):997-1004. PubMed ID: 7741772 [TBL] [Abstract][Full Text] [Related]
23. Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. Knodell RG; Hall SD; Wilkinson GR; Guengerich FP J Pharmacol Exp Ther; 1987 Jun; 241(3):1112-9. PubMed ID: 3598900 [TBL] [Abstract][Full Text] [Related]
24. Rate-limiting biotransformation of triamterene is mediated by CYP1A2. Fuhr U; Kober S; Zaigler M; Mutschler E; Spahn-Langguth H Int J Clin Pharmacol Ther; 2005 Jul; 43(7):327-34. PubMed ID: 16035375 [TBL] [Abstract][Full Text] [Related]
25. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms. Tassaneeyakul W; Birkett DJ; McManus ME; Tassaneeyakul W; Veronese ME; Andersson T; Tukey RH; Miners JO Biochem Pharmacol; 1994 May; 47(10):1767-76. PubMed ID: 8204093 [TBL] [Abstract][Full Text] [Related]
26. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Lasker JM; Wester MR; Aramsombatdee E; Raucy JL Arch Biochem Biophys; 1998 May; 353(1):16-28. PubMed ID: 9578596 [TBL] [Abstract][Full Text] [Related]
27. Biotransformation of caffeine by microsomes from human liver. Kinetics and inhibition studies. Grant DM; Campbell ME; Tang BK; Kalow W Biochem Pharmacol; 1987 Apr; 36(8):1251-60. PubMed ID: 3593412 [TBL] [Abstract][Full Text] [Related]
28. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666 [TBL] [Abstract][Full Text] [Related]
29. Oxidation of histamine H1 antagonist mequitazine is catalyzed by cytochrome P450 2D6 in human liver microsomes. Nakamura K; Yokoi T; Kodama T; Inoue K; Nagashima K; Shimada N; Shimizu T; Kamataki T J Pharmacol Exp Ther; 1998 Feb; 284(2):437-42. PubMed ID: 9454781 [TBL] [Abstract][Full Text] [Related]
30. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. Chiba K; Kobayashi K; Manabe K; Tani M; Kamataki T; Ishizaki T J Pharmacol Exp Ther; 1993 Jul; 266(1):52-9. PubMed ID: 8331574 [TBL] [Abstract][Full Text] [Related]
31. In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes. Nielsen TL; Rasmussen BB; Flinois JP; Beaune P; Brosen K J Pharmacol Exp Ther; 1999 Apr; 289(1):31-7. PubMed ID: 10086984 [TBL] [Abstract][Full Text] [Related]
32. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022 [TBL] [Abstract][Full Text] [Related]
33. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes. Campbell ME; Grant DM; Inaba T; Kalow W Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985 [TBL] [Abstract][Full Text] [Related]
34. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine. Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578 [TBL] [Abstract][Full Text] [Related]
35. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics. Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031 [TBL] [Abstract][Full Text] [Related]
36. Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes. Marre F; Fabre G; Lacarelle B; Bourrie M; Catalin J; Berger Y; Rahmani R; Cano JP Drug Metab Dispos; 1992; 20(2):316-21. PubMed ID: 1352227 [TBL] [Abstract][Full Text] [Related]
37. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes. Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340 [TBL] [Abstract][Full Text] [Related]
38. Phenacetin O-deethylation by human liver microsomes: kinetics and propranolol inhibition. Gillam EM; Reilly PE Xenobiotica; 1988 Jan; 18(1):95-104. PubMed ID: 3128014 [TBL] [Abstract][Full Text] [Related]
39. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes. Mimura M; Yamazaki H; Sugahara C; Hiroi T; Funae Y; Shimada T Biochem Pharmacol; 1994 Jun; 47(11):1957-63. PubMed ID: 7912070 [TBL] [Abstract][Full Text] [Related]
40. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. Koyama E; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]